Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Cycling News
Cycling News
Sport
Dani Ostanek

Antwan Tolhoek handed four-year ban for anabolic androgenic steroid positive

NANNING, CHINA - OCTOBER 14: Antwan Tolhoek of The Netherlands and Team Lidl-Trek competes during the 4th Gree-Tour of Guangxi 2023, Stage 3 a 134.3km stage from Nanning to Nanning / #UCIWT / on October 14, 2023 in Nanning, China. (Photo by Tim de Waele/Getty Images).

The UCI has suspended Antwan Tolhoek for four years after the former Lidl-Trek and Jumbo-Visma rider tested positive for anabolic androgenic steroids in November 2023.

News of the South African's positive test was announced last February, after he had signed for the Portuguese Continental team Sabgal-Anicolor. He had previously raced for Jumbo-Visma from 2017 to 2021 before racing for Lidl-Trek in 2022 and 2023.

Former speed skater Tolhoek's positive sample was returned in an out-of-competition test on November 27, 2023. He was subsequently provisionally suspended by the UCI and fired by Sabgal-Anicolor.

On Wednesday, the UCI announced that the 31-year-old will serve a four-year ban, running from February 7, 2024, to February 6, 2028.

"The Union Cycliste Internationale (UCI) announces that the UCI Anti-Doping Tribunal has rendered a decision against Dutch rider Antwan Tolhoek," the UCI announced.

"The Tribunal found the rider guilty of an anti-doping rule violation (presence of Anabolic Androgenic Steroids) and imposed a four-year period of ineligibility on the rider.

"In accordance with the World Anti-Doping Code and the UCI Anti-Doping Rules, the period of ineligibility started on 7 February 2024 and will remain in force until 6 February 2028."

The UCI stated that Tolhoek may appeal the decision to the Court of Arbitration for Sport (CAS) within a month.

"In line with the Procedural Rules of the Tribunal, the decision will be published on the UCI website. This decision may be appealed before the CAS within one month.

"The UCI will not comment further on the matter."

Tolhoek turned pro with Roompot in 2016, having only taken up road racing two years earlier. He scored a single victory during his career, beating Egan Bernal to win stage 6 of the 2019 Tour de Suisse.

In 2017, he was suspended for two months by Jumbo-Visma after he and two teammates, Pascal Eenkhoorn and Juan José Lobato, were found to have taken sleeping medication outside the team's supervision while at training camp.

Cyclingnews has reached out to Tolhoek's former team, Lidl-Trek, for comment on the matter.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.